참고문헌 (32)

1. 1. Kubitza D. Becka M. Wensing G. Voith B. Zuehlsdorf M. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939―An oral, direct Factor Xa inhibitor―After multiple dosing in healthy male subjects Eur. J. Clin. Pharmacol. 2005 61 873 880 10.1007/s00228-005-0043-5 16328318 

   상세보기

2. 2. Kapourani A. Vardaka E. Katopodis K. Kachrimanis K. Barmpalexis P. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions Eur. J. Pharm. Biopharm. 2019 145 98 112 10.1016/j.ejpb.2019.10.010 31698042 

   상세보기

3. 3. Metre S. Mukesh S. Samal S.K. Chand M. Sangamwar A.T. Enhanced biopharmaceutical performance of rivaroxaban through polymeric amorphous solid dispersion Mol. Pharm. 2018 15 652 668 10.1021/acs.molpharmaceut.7b01027 29287144 

   상세보기

4. 4. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 2005 4 145 160 10.1038/nrd1632 15688077 

   상세보기

5. 5. Gao Y. Li Z. Sun M. Li H. Guo C. Cui J. Li A. Cao F. Xi Y. Lou H. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer Drug Dev. Ind. Pharm. 2010 36 1225 1234 10.3109/03639041003695139 20545506 

   상세보기

6. 6. Wan S. Sun Y. Qi X. Tan F. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion AAPS PharmSciTech 2011 13 159 166 10.1208/s12249-011-9732-9 22173375 

   상세보기

7. 7. Wang D. Chen G. Ren L. Preparation and characterization of the sulfobutylether-β-cyclodextrin inclusion complex of amiodarone hydrochloride with enhanced oral bioavailability in fasted state AAPS PharmSciTech 2017 18 1526 1535 10.1208/s12249-016-0646-4 27757923 

   상세보기

8. 8. Gurusamy S. Umar V.I.K. Ishra D.N.M. Preparation, characterization and in vitro dissolution studies of solid dispersion Yakugaku Zasshi 2006 126 657 664 16880724 

9. 9. Papageorgiou G.Z. Bikiaris D. Karavas E. Politis S. Docoslis A. Park Y. Stergiou A. Georgarakis E. Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation AAPS J. 2006 8 E623 E631 10.1208/aapsj080471 17233527 

   상세보기

10. 10. Sethia S. Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods Int. J. Pharm. 2004 272 1 10 10.1016/j.ijpharm.2003.11.025 15019063 

    상세보기

11. 11. Shin S.-C. Cho C. Physicochemical characterizations of piroxicam-poloxamer solid dispersion Pharm. Dev. Technol. 1997 2 403 407 10.3109/10837459709022639 9552469 

    상세보기

12. 12. Verreck G. Six K. Mooter G.V.D. Baert L. Peeters J. Brewster M.E. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion―Part I Int. J. Pharm. 2003 251 165 174 10.1016/S0378-5173(02)00591-4 12527186 

    상세보기

13. 13. Zajc N. Obreza A. Bele M. Sri S. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method Int. J. Pharm. 2005 291 51 58 10.1016/j.ijpharm.2004.07.042 15707731 

    상세보기

14. 14. Chen Y. Zhang G. Neilly J. Marsh K. Mawhinney D. Sanzgiri Y. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68 Int. J. Pharm. 2004 286 69 80 10.1016/j.ijpharm.2004.08.009 15501003 

    상세보기

15. 15. Chokshi R.J. Sandhu H.K. Iyer R.M. Shah N.H. Malick A. Zia H. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution J. Pharm. Sci. 2005 94 2463 2474 10.1002/jps.20385 16200544 

    상세보기

16. 16. Shah S. Maddineni S. Lu J. Repka M.A. Melt extrusion with poorly soluble drugs Int. J. Pharm. 2013 453 233 252 10.1016/j.ijpharm.2012.11.001 23178213 

    상세보기

17. 17. Huang D. Xie Z. Rao Q. Liamas E. Pan P. Li Q. Zhang Z.J. Lu M. Li Q. Hot melt extrusion of heat-sensitive and high melting point drug: Inhibit the recrystallization of the prepared amorphous drug during extrusion to improve the bioavailability Int. J. Pharm. 2019 565 316 324 10.1016/j.ijpharm.2019.04.064 31022504 

    상세보기

18. 18. Vasoya J.M. Desai H.H. Gumaste S.G. Tillotson J. Kelemen D. Dalrymple D.M. Serajuddin A.T.M. Development of solid dispersion by hot melt extrusion using mixtures of polyoxylglycerides with polymers as carriers for increasing dissolution rate of a poorly soluble drug model J. Pharm. Sci. 2019 108 888 896 10.1016/j.xphs.2018.09.019 30257196 

    상세보기

19. 19. Alshetaili A.S. Almutairy B.K. Alshahrani S.M. Ashour E.A. Tiwari R.V. AlShehri S.M. Feng X. Alsulays B.B. Majumdar S. Langley N. Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets Drug Dev. Ind. Pharm. 2016 42 1833 1841 10.1080/03639045.2016.1178769 27080252 

    상세보기

20. 20. Alshahrani S.M. Lu W. Park J.-B. Morott J.T. Alsulays B.B. Majumdar S. Langley N. Kolter K. Gryczke A. Repka M.A. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus ® and HPMCAS-HF AAPS PharmSciTech 2015 16 824 834 10.1208/s12249-014-0269-6 25567525 

    상세보기

21. 21. Justine T. Pieere L. Chole V. Martine A. Laureanne N. Eric Z. Philippe H. Krier F. Evrard B. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination Int. J. Pharm. 2016 151 114 124 10.1016/j.ijpharm.2016.10.003 

    상세보기

22. 22. Fan W. Zhang X. Zhu W. Di L. The preparation of curcumin sustained-release solid dispersion by hot melt extrusion-II. Optimization of preparation process and evaluation in vitro and in vivo J. Pharm. Sci. 2020 109 1253 1260 10.1016/j.xphs.2019.11.020 31794699 

    상세보기

23. 23. Mogal V. Dusane J. Borase P. Thakare P. Kshirsagar S. A review on quality by design Pharm. Biol. Eval. 2016 3 313 319 

24. 24. Sarwar B.M. Saquib H. Pharmaceutical Quality by Design―Principles and Applications 1st ed. Elsevier Amsterdam, The Netherlands 2019 

25. 25. Costa P. Sousa Lobo J.M. Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2001 13 123 133 10.1016/S0928-0987(01)00095-1 

    상세보기

26. 26. Wang L. Gai S. Zhang X. Xu X. Gou N. Wang X. Zhou N. Feng T. Simultaneous determination of RXB and TAK-438 in rat plasma by LC？MS/MS: Application to pharmacokinetic interaction study Bioanalysis 2020 12 11 22 10.4155/bio-2019-0130 31849262 

    상세보기

27. 27. Gibaldi M. Perrier D. Pharmacokinetics Revised and Expanded 2nd ed. Marcel Dekker, Inc. New York, NY, USA 1982 409 416 

28. 28. Patil H. Tiwari R.V. Repka M.A. Hot-melt extrusion: From theory to application in pharmaceutical formulation AAPS Pharm. 2016 17 20 42 10.1208/s12249-015-0360-7 

    상세보기

29. 29. Pawar J. Tayade A. Gangurde A. Moravkar K. Amin P. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach Eur. J. Pharm. Sci. 2016 88 37 49 10.1016/j.ejps.2016.04.001 27049050 

    상세보기

30. 30. Al-Zoubi N. Alkhatib H.S. Bustanji Y.K. Aiedeh K. Malamataris S. Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions Eur. J. Pharm. Biopharm. 2008 69 735 742 10.1016/j.ejpb.2008.01.002 18291632 

    상세보기

31. 31. Godfrey K.R. Arundel P.A. Dong Z. Bryant R. Modelling the double peak phenomenon in pharmacokinetics Comput. Methods Programs Biomed. 2011 104 62 69 10.1016/j.cmpb.2010.03.007 20381191 

    상세보기

32. 32. Kim M. Son H. Noh K. Kim E. Shin B.S. Kang W. Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of rivaroxaban Pharmaceutics 2019 11 133 10.3390/pharmaceutics11030133 30893910 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.